BIO-AVAILABILITY AND BIO-EQUIVALENCE AND CLINICAL STUDIES
( DCGI, USFDA, UK-MHRA, Chile, ANVISA, TGA and WHO Approved Clinical Research Site )
- Independent Monitoring-GCP, GLP, GMP
- CRO, Principal Investigator Selection
- Outsourcing Bioequivalence and Clinical studies
- Study Reports and Data review- retrospective Audit
- System Audit of CRO, CMO, Plants,
- Business Development for CRO, CMO